Door Pharmaceuticals

Biotechnology company · Bloomington, Indiana, United States

Door Pharmaceuticals is a biotechnology company headquartered in Bloomington, Indiana, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $306,500 in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Door Pharmaceuticals at a glance

Typebiotechnology company

HeadquartersBloomington, Indiana, United States

Employees (self-reported, 2024)6

What does Door Pharmaceuticals do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $306,500 in total (2024). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Frequently asked questions about Door Pharmaceuticals

Where is Door Pharmaceuticals headquartered?

Door Pharmaceuticals is headquartered in Bloomington, Indiana, United States.

What does Door Pharmaceuticals do?

Door Pharmaceuticals is a biotechnology company.

Similar companies

Medosome Biotec, LLCBloomington, Indiana, United States
Innovative Surgical Designs, Inc.Bloomington, Indiana, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences